Literature DB >> 1607890

Neopterin concentrations in serum and cerebrospinal fluid in HTLV-I infected individuals.

A Ali1, P Rudge, A G Dalgleish.   

Abstract

The concentration of neopterin was measured in serum samples taken from individuals infected with HTLV-I: 5 from asymptomatic individuals, 1 from a patient with adult T-cell leukaemia and 30 from patients with tropical spastic paraparesis (TSP). In addition, cerebrospinal fluid (CSF) was available from 22 of the TSP patients and neopterin concentrations were determined in these. Elevated levels of neopterin were found in only 3 of the 36 HTLV-I-positive serum samples, all from TSP patients, but significantly elevated neopterin levels were observed in 12 of the 22 CSF samples. The localisation of the elevated neopterin concentrations to the CSF of patients with TSP suggests a marked degree of activation of the cell-mediated immune system intrathecally. This provides further evidence in favour of powerful immune mechanisms operating centrally in the pathogenesis of TSP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1607890     DOI: 10.1007/bf00810351

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  CLINICAL AND PATHOLOGICAL OBSERVATIONS ON JAMAICAN NEUROPATHY; A REPORT ON 206 CASES.

Authors:  R D MONTGOMERY; E K CRUICKSHANK; W B ROBERTSON; W H MCMENEMEY
Journal:  Brain       Date:  1964-09       Impact factor: 13.501

2.  An improved immunoblotting procedure for the detection of antibodies against HIV.

Authors:  R Thorpe; M D Brasher; C R Bird; A J Garrett; J P Jacobs; P D Minor; G C Schild
Journal:  J Virol Methods       Date:  1987-05       Impact factor: 2.014

3.  Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1.

Authors:  D Fuchs; F Chiodi; J Albert; B Asjö; L Hagberg; A Hausen; G Norkrans; G Reibnegger; E R Werner; H Wachter
Journal:  AIDS       Date:  1989-05       Impact factor: 4.177

4.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

5.  Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies.

Authors:  M Elian; G Dean
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

6.  Tryptophan degradation in patients infected by human immunodeficiency virus.

Authors:  E R Werner; D Fuchs; A Hausen; H Jaeger; G Reibnegger; G Werner-Felmayer; M P Dierich; H Wachter
Journal:  Biol Chem Hoppe Seyler       Date:  1988-05

7.  Methods in laboratory investigation. Application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human t cell leukemia-lymphoma virus.

Authors:  C Saxinger; R C Gallo
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

8.  Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease.

Authors:  D E Griffin; J C McArthur; D R Cornblath
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

9.  Raised serum neopterin levels and imbalances of T-lymphocyte subsets in viral diseases, acquired immune deficiency and related lymphadenopathy syndromes.

Authors:  P Kern; H Rokos; M Dietrich
Journal:  Biomed Pharmacother       Date:  1984       Impact factor: 6.529

10.  Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.

Authors:  C Huber; J R Batchelor; D Fuchs; A Hausen; A Lang; D Niederwieser; G Reibnegger; P Swetly; J Troppmair; H Wachter
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

View more
  5 in total

1.  HTLV-I-associated myelopathy: are ferritin, S100beta protein, or guanine nucleotides CSF markers of disease?

Authors:  Andrea Regner; Ottomar Bianchini; Claudio Jardim; Marcio Menna-Barreto
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

2.  CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Tomoo Sato; Ariella Coler-Reilly; Atae Utsunomiya; Natsumi Araya; Naoko Yagishita; Hitoshi Ando; Junji Yamauchi; Eisuke Inoue; Takahiko Ueno; Yasuhiro Hasegawa; Kusuki Nishioka; Toshihiro Nakajima; Steven Jacobson; Shuji Izumo; Yoshihisa Yamano
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10

3.  Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.

Authors:  Massanobu Takatani; Myuki Esashika Crispim; Nelson Fraiji; Mariane Martins Araujo Stefani; Dagmar Kiesslich
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-04-03       Impact factor: 1.846

Review 4.  Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases.

Authors:  Nicolas Futsch; Gabriela Prates; Renaud Mahieux; Jorge Casseb; Hélène Dutartre
Journal:  Viruses       Date:  2018-12-05       Impact factor: 5.048

5.  Loss of memory CD4+ T-cells in semi-wild mandrills (Mandrillus sphinx) naturally infected with species-specific simian immunodeficiency virus SIVmnd-1.

Authors:  Edward J D Greenwood; Fabian Schmidt; Florian Liégeois; Ivanela Kondova; Anaïs Herbert; Barthelemy Ngoubangoye; François Rouet; Jonathan L Heeney
Journal:  J Gen Virol       Date:  2013-11-08       Impact factor: 3.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.